BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37860270)

  • 1. Beyond the WHO classification of meningioma: using molecular diagnostics to guide management.
    Clynch A; Richardson GE; Mustafa MA; Gillespie CS; Rathi N; Bakhsh A; Zakaria R; Islim AI; Millward CP; Jenkinson MD
    Adv Clin Neurosci Rehabil; 2023 Aug; 22(2):WVJZ9783. PubMed ID: 37860270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.
    Roehrkasse AM; Peterson JEG; Fung KM; Pelargos PE; Dunn IF
    Front Oncol; 2022; 12():846232. PubMed ID: 35299730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular classification and grading of meningioma.
    Nasrallah MP; Aldape KD
    J Neurooncol; 2023 Jan; 161(2):373-381. PubMed ID: 36802047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological classification and molecular genetics of meningiomas.
    Riemenschneider MJ; Perry A; Reifenberger G
    Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".
    Compérat EM; Burger M; Gontero P; Mostafid AH; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Sylvester RJ; Zigeuner R; Babjuk M
    Eur Urol Focus; 2019 May; 5(3):457-466. PubMed ID: 29366854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Practical Overview on the Molecular Biology of Meningioma.
    Delgado-López PD; Cubo-Delgado E; González-Bernal JJ; Martín-Alonso J
    Curr Neurol Neurosci Rep; 2020 Nov; 20(12):62. PubMed ID: 33136206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation profiling of a lipomatous meningioma: illustrative case.
    Patel Z; Wang JZ; Merali Z; Patil V; Nassiri F; Wei Q; Sosa J; Coire C; Zadeh G
    J Neurosurg Case Lessons; 2023 Feb; 5(6):. PubMed ID: 36748749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrochemical differentiation of meningioma tumours based on attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy.
    Lilo T; Morais CLM; Ashton KM; Pardilho A; Davis C; Dawson TP; Gurusinghe N; Martin FL
    Anal Bioanal Chem; 2020 Feb; 412(5):1077-1086. PubMed ID: 31865413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in meningioma genetics: novel therapeutic opportunities.
    Preusser M; Brastianos PK; Mawrin C
    Nat Rev Neurol; 2018 Feb; 14(2):106-115. PubMed ID: 29302064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours.
    Sahm F; Reuss DE; Giannini C
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):163-171. PubMed ID: 28295484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular pattern of histopathological progression to anaplastic meningioma - A case report.
    Och W; Kulbacki K; Szostak B; Sikorska B; Zakrzewska M; Szmuda T; Liberski PP; Budzisz T
    Neurol Neurochir Pol; 2016; 50(4):288-93. PubMed ID: 27375146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation meningioma biomarkers: attributes and limitations.
    Li Z; Gao Y; Zhang J; Han L; Zhao H
    Front Mol Neurosci; 2023; 16():1182759. PubMed ID: 37492524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours.
    Horbinski C; Berger T; Packer RJ; Wen PY
    Nat Rev Neurol; 2022 Sep; 18(9):515-529. PubMed ID: 35729337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of body mass index and height on risk for primary tumours of the spinal cord, spinal meninges, spinal and peripheral nerves in 1.7 million norwegian women and men: a prospective cohort study.
    Gheorghiu A; Brunborg C; Johannesen TB; Helseth E; Zwart JA; Wiedmann MKH
    Acta Oncol; 2022 Jan; 61(1):1-6. PubMed ID: 35001805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study.
    Schepke E; Löfgren M; Pietsch T; Olsson Bontell T; Kling T; Wenger A; Ferreyra Vega S; Danielsson A; Dosa S; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sandström PE; Pfister SM; Lannering B; Sabel M; Carén H
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12838. PubMed ID: 35892159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of brain tumours with spin-spin relaxation: pilot case study reveals unique T
    Laule C; Bjarnason TA; Vavasour IM; Traboulsee AL; Wayne Moore GR; Li DKB; MacKay AL
    J Neurol; 2017 Nov; 264(11):2205-2214. PubMed ID: 28894952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5.
    Ahmad Z; Rahim S; Abdul-Ghafar J; Chundriger Q; Ud Din N
    Int J Gen Med; 2023; 16():107-127. PubMed ID: 36644568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist.
    McNamara C; Mankad K; Thust S; Dixon L; Limback-Stanic C; D'Arco F; Jacques TS; Löbel U
    Neuroradiology; 2022 Oct; 64(10):1919-1950. PubMed ID: 35869291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.